The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Cysteine depletion induces pancreatic tumor ferroptosis in mice
Open accessAbstract
Ferroptotic cell death and cancer: Cell death can occur through different mechanisms, several of which are being explored as potential targets for cancer treatment. One form of cell death that has attracted recent interest is ferroptosis, which is triggered by high intracellular levels of lipid reactive oxygen species. Pancreatic cancer cells have high levels of reactive oxygen species but manage to avoid ferroptosis by importing extracellular cysteine. Studying mice bearing pancreatic tumors, Badgley et al. found that administration of a drug inhibiting cysteine import induced tumor-selective ferroptosis and inhibited tumor growth. Further work will be required to determine whether this therapeutic strategy will be effective in human pancreatic cancer, a tumor type for which new treatments are urgently needed. Science , this issue p. 85
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Reflecting on recent reports suggesting that depletion of CoA contributes to the induction of ferroptosis by erastin (25, 26)”
From Eprenetapopt triggers ferroptosis, inhibits NFS1 cysteine desulfurase, and synergizes with serine and glycine dietary restriction (2022) · cites this paper as [25]
Experimental — accuracy not yet measuredIn the citing paper
“Labile iron can also potentiate cell death via the lipid oxidation process known as “ferroptosis”218”
From Pancreatic cancer: Advances and challenges (2023) · cites this paper as [218]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2
Love, M. I., Huber, W., & Anders, S. (2014) · Genome Biology · doi:10.1186/s13059-014-0550-8 · Cited by 95,106
Subramanian, A., Tamayo, P., Mootha, V. K., Mukherjee, S., Ebert, B. L., Gillette, M. A., Paulovich, A., Pomeroy, S. L., Golub, T. R., Lander, E. S., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506580102 · Cited by 53,625
limma powers differential expression analyses for RNA-sequencing and microarray studies
Ritchie, M. E., Phipson, B., Wu, D., Hu, Y., Law, C. W., Shi, W., & Smyth, G. K. (2015) · Nucleic Acids Research · doi:10.1093/nar/gkv007 · Cited by 40,458
Conducting Meta-Analyses in R with the metafor Package
Viechtbauer, W. (2010) · Journal of Statistical Software · doi:10.18637/jss.v036.i03 · Cited by 20,464
Ferroptosis: An Iron-Dependent Form of Nonapoptotic Cell Death
Dixon, S. J., Lemberg, K. M., Lamprecht, M. R., Skouta, R., Zaitsev, E. M., Gleason, C. E., Patel, D. N., Bauer, A. J., Cantley, A. M., Yang, W. S., et al. (2012) · Cell · doi:10.1016/j.cell.2012.03.042 · Cited by 18,691
Self-citationGSVA: gene set variation analysis for microarray and RNA-Seq data
Hänzelmann, S., Castelo, R., & Guinney, J. (2013) · BMC Bioinformatics · doi:10.1186/1471-2105-14-7 · Cited by 15,440
Regulation of Ferroptotic Cancer Cell Death by GPX4
Yang, W. S., SriRamaratnam, R., Welsch, M. E., Shimada, K., Skouta, R., Viswanathan, V. S., Cheah, J. H., Clemons, P. A., Shamji, A. F., Clish, C. B., et al. (2014) · Cell · doi:10.1016/j.cell.2013.12.010 · Cited by 7,713
Self-citationInactivation of the ferroptosis regulator Gpx4 triggers acute renal failure in mice
Friedmann Angeli, J. P., Schneider, M., Proneth, B., Tyurina, Y. Y., Tyurin, V. A., Hammond, V. J., Herbach, N., Aichler, M., Walch, A., Eggenhofer, E., et al. (2014) · Nature Cell Biology · doi:10.1038/ncb3064 · Cited by 3,732
Self-citationGenomic analyses identify molecular subtypes of pancreatic cancer
Bailey, P., Chang, D. K., Nones, K., Johns, A. L., Patch, A.-M., Gingras, M.-C., Miller, D. K., Christ, A. N., Bruxner, T. J. C., Quinn, M. C., et al. (2016) · Nature · doi:10.1038/nature16965 · Cited by 3,621
GEOquery: a bridge between the Gene Expression Omnibus (GEO) and BioConductor
Davis, S. R., & Meltzer, P. S. (2007) · Bioinformatics · doi:10.1093/bioinformatics/btm254 · Cited by 3,316
Research works printed but not linked: 1
- T. M. Therneau P. M. Grambsch Modeling Survival Data: Extending the Cox Model (Springer 2013).
Cited by
Sorted by citations
Items 401–500 of 1,001
Melatonin and ferroptosis: Mechanisms and therapeutic implications
Zhang, D., Jia, X., Lin, D., & Ma, J. (2023) · Biochemical Pharmacology · doi:10.1016/j.bcp.2023.115909 · Cited by 39
Ge, A., He, Q., Da, Z., Li, Y., Chen, J., Deng, Y., Xiang, W., Fan, H., Wu, S., Li, Y., et al. (2023) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.18044 · Cited by 40
ARID3A enhances chemoresistance of pancreatic cancer via inhibiting PTEN-induced ferroptosis
Mao, X., Xu, J., Xiao, M., Chen, L., Hua, J., Liu, J., Wang, W., Yu, X., Meng, Q., & Shi, S. (2024) · Redox Biology · doi:10.1016/j.redox.2024.103200 · Cited by 39
Guo, D., Cai, S., Deng, L., Xu, W., Fu, S., Lin, Y., Jiang, T., Li, X., Shen, Z., Zhang, J., et al. (2025) · MedComm · doi:10.1002/mco2.70116 · Cited by 44
Contribution of Lipid Oxidation and Ferroptosis to Radiotherapy Efficacy
Pearson, A. N., Carmicheal, J., Jiang, L., Lei, Y. L., & Green, M. D. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222212603 · Cited by 41
Non-coding RNAs in ferroptotic cancer cell death pathway: meet the new masters
Valashedi, M. R., Bamshad, C., Najafi-Ghalehlou, N., Nikoo, A., Tomita, K., Kuwahara, Y., Sato, T., Roushandeh, A. M., & Roudkenar, M. H. (2022) · Human Cell · doi:10.1007/s13577-022-00699-0 · Cited by 39
Yuan, Y., He, M., Wang, L., Shen, X., & Chen, H. (2023) · Sensors and Actuators B Chemical · doi:10.1016/j.snb.2023.134600 · Cited by 38
Ferroptosis resistance in cancer: recent advances and future perspectives
Zhang, X., Li, X., Ran, X., & Zhang, H. (2023) · Biochemical Pharmacology · doi:10.1016/j.bcp.2023.115933 · Cited by 38
Liu, Y., Li, J., Xu, J., Long, Y., Wang, Y., Liu, X., Hu, J., Wei, Q., Luo, Q., Luo, F., et al. (2024) · Oncogene · doi:10.1038/s41388-024-03185-z · Cited by 38
Self-citationPD-L1 protects tumor-associated dendritic cells from ferroptosis during immunogenic chemotherapy
Xiao, K., Zhang, S., Qi, P., Du, Y., Yao, X., Ng, I.-I., & Tang, H. (2024) · Cell Reports · doi:10.1016/j.celrep.2024.114868 · Cited by 40
Cancer metabolism and dietary interventions
Qian, L., Zhang, F., Yin, M., & Lei, Q. (2021) · Cancer Biology and Medicine · doi:10.20892/j.issn.2095-3941.2021.0461 · Cited by 40
Chi, H., Zhu, G., Yin, Y., Diao, H., Liu, Z., Sun, S., Guo, Z., Xu, W., Xu, J., Cui, C., et al. (2022) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2022.121898 · Cited by 38
Molecular Mechanisms of Ferroptosis and Updates of Ferroptosis Studies in Cancers and Leukemia
Akiyama, H., Carter, B. Z., Andreeff, M., & Ishizawa, J. (2023) · Cells · doi:10.3390/cells12081128 · Cited by 38
High-Dose Selenium Induces Ferroptotic Cell Death in Ovarian Cancer
Choi, J.-A., Lee, E. H., Cho, H., & Kim, J. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24031918 · Cited by 38
Membrane transporters in cell physiology, cancer metabolism and drug response
Alam, S., Doherty, E., Ortega-Prieto, P., Arizanova, J., & Fets, L. (2023) · Disease Models & Mechanisms · doi:10.1242/dmm.050404 · Cited by 44
Ferroptosis: Emerging Role in Diseases and Potential Implication of Bioactive Compounds
Patanè, G. T., Putaggio, S., Tellone, E., Barreca, D., Ficarra, S., Maffei, C., Calderaro, A., & Laganà, G. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242417279 · Cited by 40
Ferroptosis-Based Therapeutic Strategies toward Precision Medicine for Cancer
Shi, T., Chen, X., & Ti, H. (2024) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.3c01749 · Cited by 38
Recent advances in the development of metallodrugs for cancer chemoimmunotherapy
Wei, F., Liang, J., Shen, X., Pan, Y., He, Y., & Chao, H. (2024) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2024.216319 · Cited by 38
Ferroptosis in Cancer and Inflammatory Diseases: Mechanisms and Therapeutic Implications
Shen, G., Liu, J., Wang, Y., Deng, Z., & Deng, F. (2025) · MedComm · doi:10.1002/mco2.70349 · Cited by 47
SLC7A11 as a bridge between ferroptosis and disulfidptosis: a promising target for tumor treatment
Qiu, H., Liu, J., Shao, N., Zhao, J., Chen, C., Jiang, Y., Zhao, X., & Xu, L. (2025) · Cell Communication and Signaling · doi:10.1186/s12964-025-02447-x · Cited by 48
Kato, I., Kasukabe, T., & Kumakura, S. (2020) · International Journal of Oncology · doi:10.3892/ijo.2020.5116 · Cited by 38
The DUBA-SLC7A11-c-Myc Axis is Critical for Stemness and Ferroptosis
Wang, Z., Ouyang, L., Liu, N., Li, T., Yan, B., Mao, C., Xiao, D., Gan, B., Liu, S., & Tao, Y. (2022) · Oncogene · doi:10.1038/s41388-023-02744-0 · Cited by 36
Zhang, C., Lu, S., Deng, K. Y., Qian, W., Liu, Y., Li, Y., Jin, S., Suo, R., Xu, H., & Wu, B. (2023) · Advanced Functional Materials · doi:10.1002/adfm.202301462 · Cited by 36
Tang, J., Zeng, J., Chen, L., Wang, M., He, S., Muhmood, A., Chen, X., Huang, K., & Gan, F. (2023) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.3c04560 · Cited by 36
Ferroptosis Inducers as Promising Radiosensitizer Agents in Cancer Radiotherapy
Jalali-Zefrei, F., Shormij, M., Dastranj, L., Alvandi, M., Shaghaghi, Z., Farzipour, S., & Polgardani, N. Z. (2023) · Current Radiopharmaceuticals · doi:10.2174/0118744710262369231110065230 · Cited by 39
Yuan, C., Fan, R., Zhu, K., Wang, Y., Xie, W., & Liang, Y. (2023) · Experimental Biology and Medicine · doi:10.1177/15353702231220670 · Cited by 36
Ashoub, M. H., Razavi, R., Heydaryan, K., Salavati‐Niasari, M., & Amiri, M. (2024) · European journal of medical research · doi:10.1186/s40001-024-01822-7 · Cited by 37
Unlocking ferroptosis in prostate cancer — the road to novel therapies and imaging markers
Cao, P. H. A., Dominic, A., Lujan, F. E., Senthilkumar, S., Bhattacharya, P. K., Frigo, D. E., & Subramani, E. (2024) · Nature Reviews Urology · doi:10.1038/s41585-024-00869-9 · Cited by 43
Targeted tumor therapy with L-cyst(e)ine-addicted bacteria-nanodrug biohybrids
Wang, Y., Chen, W., Han, Z., Zhang, S., Ji, P., Zhang, C., Liang, J., & Zhang, X. (2025) · Cell Metabolism · doi:10.1016/j.cmet.2025.03.012 · Cited by 36
Wang, F., Graham, E. T., Naowarojna, N., Shi, Z., Wang, Y., Xie, G., Zhou, L., Salmon, W. C., Jia, J., Wang, X., et al. (2021) · Cell chemical biology · doi:10.1016/j.chembiol.2021.11.001 · Cited by 35
The crosstalk effect between ferrous and other ions metabolism in ferroptosis for therapy of cancer
Ke, K., Li, L., Lü, C., Zhu, Q., Wang, Y., Mou, Y., Wang, H., & Jin, W. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.916082 · Cited by 36
DNA damage and metabolic mechanisms of cancer drug resistance
Tiek, D. M., & Cheng, S. (2022) · Cancer Drug Resistance · doi:10.20517/cdr.2021.148 · Cited by 39
Dong, J., Du, C., Xu, C., Wang, Q., Wang, Z., Zeng, F., Qian, Z., Zhang, L., Lv, X., Lei, Z., et al. (2023) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2023.116227 · Cited by 35
Self-citationWang, H., Fan, S., Zhan, Y., Peng, S., & Wang, W. (2023) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2023.127976 · Cited by 35
ER remodeling via lipid metabolism
Jang, W., & Haucke, V. (2024) · Trends in Cell Biology · doi:10.1016/j.tcb.2024.01.011 · Cited by 35
Li, L., Zhang, Z., Zhou, L., Ge, H., Zhao, Y., Gong, Y., Mao, G.-J., & Liu, H. (2024) · Analytical Chemistry · doi:10.1021/acs.analchem.4c00922 · Cited by 35
Ferroptosis-like cell death promotes and prolongs inflammation in Drosophila
Davidson, A. J., Heron, R., Das, J., Overholtzer, M., & Wood, W. (2024) · Nature Cell Biology · doi:10.1038/s41556-024-01450-7 · Cited by 41
Lactate dehydrogenase B noncanonically promotes ferroptosis defense in KRAS-driven lung cancer
Zhao, L., Deng, H., Zhang, J., Zamboni, N., Yang, H., Gao, Y., Zhang, Y., Xu, D., Zhong, H., van Geest, G., et al. (2024) · Cell Death and Differentiation · doi:10.1038/s41418-024-01427-x · Cited by 43
Alothaim, T., Charbonneau, M., & Tang, X. (2021) · Scientific Reports · doi:10.1038/s41598-021-90527-6 · Cited by 36
Oxidase Mimic Graphdiyne for Efficient Superoxide Generation in Wide pH Ranges
Gu, Y., Fan, C., Hao, X., Hu, F., Zhang, C., Yang, H., Li, C. M., & Guo, C. (2021) · Advanced Functional Materials · doi:10.1002/adfm.202110192 · Cited by 35
The dark side of ferroptosis in pancreatic cancer
Liu, J., Dai, E., Kang, R., Kroemer, G., & Tang, D. (2021) · OncoImmunology · doi:10.1080/2162402x.2020.1868691 · Cited by 35
Zhao, X., Zhou, T.-R., Wang, Y., Bao, M., Ni, C., Ding, L., Sun, S., Dong, H., Li, J., & Liang, C. (2023) · Cancer Science · doi:10.1111/cas.15763 · Cited by 34
From mechanisms to medicine: Ferroptosis as a Therapeutic target in liver disorders
He, Y., Lin, Y., Song, J., Song, M., Nie, X., Sun, H. J., Xu, C., Han, Z., & Cai, J. (2025) · Cell Communication and Signaling · doi:10.1186/s12964-025-02121-2 · Cited by 36
Dimethyl Fumarate Induces Metabolic Crisie to Suppress Pancreatic Carcinoma
Chen, K., Wu, S., Ye, S., Huang, H., Zhou, Y., Zhou, H., Wu, S., Mao, Y., Shangguan, F., Lan, L., et al. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.617714 · Cited by 35
Pandrangi, S. L., Chittineedi, P., Chalumuri, S. S., Meena, A. S., Mosquera, J. A. N., Llaguno, S. N. S., Pamuru, R. R., Mohiddin, G. J., & Mohammad, A. (2022) · Molecules · doi:10.3390/molecules27093011 · Cited by 38
Ferroptosis As Ultimate Target of Cancer Therapy
Motooka, Y., & Toyokuni, S. (2022) · Antioxidants and Redox Signaling · doi:10.1089/ars.2022.0048 · Cited by 36
Glutamine deprivation induces ferroptosis in pancreatic cancer cells
Xiao, Z., Deng, S., Liu, H., Wang, R., Liu, Y., Dai, Z., Gu, W., Ni, Q., Yu, X., Liu, C., et al. (2023) · Acta Biochimica et Biophysica Sinica · doi:10.3724/abbs.2023029 · Cited by 34
Self-citationMETTL9-SLC7A11 axis promotes hepatocellular carcinoma progression through ferroptosis inhibition
Bi, F., Qiu, Y., Wu, Z., Liu, S., Zuo, D., Huang, Z., Li, B., Yuan, Y., Niu, Y., & Qiu, J. (2023) · Cell Death Discovery · doi:10.1038/s41420-023-01723-4 · Cited by 33
Zeng, J., Liu, M., Yang, T., Li, S., Cheng, D., & He, L. (2023) · Talanta · doi:10.1016/j.talanta.2023.125610 · Cited by 33
Ma, K., Yang, H., Shen, T., Yue, Y., Zhao, L., Liu, X., Huo, F., & Yin, C. (2022) · Chemical Science · doi:10.1039/d2sc00328g · Cited by 33
Ji, C., Guo, P., Han, M., Chen, K., Qin, J., & Yang, F. (2023) · Phytotherapy Research · doi:10.1002/ptr.7807 · Cited by 33
The Ubiquitin–Proteasome System in Tumor Metabolism
Wang, J., Xiang, Y., Fan, M., Fang, S., & Hua, Q. (2023) · Cancers · doi:10.3390/cancers15082385 · Cited by 32
Ferrada, L., Barahona, M. J., Vera, M., Stockwell, B. R., & Nualart, F. (2023) · Cell Death and Disease · doi:10.1038/s41419-023-06153-9 · Cited by 36
Self-citationMultiomic screening of invasive GBM cells reveals targetable transsulfuration pathway alterations
Garcia, J. H., Akins, E. A., Jain, S., Wolf, K. J., Zhang, J., Choudhary, N. R., Lad, M., Shukla, P. D., Rios, J., Seo, K., et al. (2023) · Journal of Clinical Investigation · doi:10.1172/jci170397 · Cited by 34
A guide to ferroptosis in cancer
Yapici, F. I., Bebber, C. M., & von Karstedt, S. (2024) · Molecular Oncology · doi:10.1002/1878-0261.13649 · Cited by 35
Targeting pancreatic cancer glutamine dependency confers vulnerability to GPX4-dependent ferroptosis
Shen, X., Chen, Y., Tang, Y., Lu, P., Liu, M., Mao, T., Weng, Y., Yu, F., Liu, Y., Tang, Y., et al. (2025) · Cell Reports Medicine · doi:10.1016/j.xcrm.2025.101928 · Cited by 33
MOMP: A critical event in cell death regulation and anticancer treatment
Liu, D., Liu, Z., Yan, H., Xiong, W., Wang, D., & Zeng, Z. (2025) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2025.189280 · Cited by 34
Yan, Y., Cai, J., Huang, Z., Cao, X., Tang, P., Wang, Z., Zhang, F., Xia, S., & Shen, B. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.712230 · Cited by 33
Chisari, A. N., Golán, I., Campisano, S., Gélabert, C., Moustakas, A., Sancho, P., & Caja, L. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.723798 · Cited by 33
Cellular metabolism in pancreatic cancer as a tool for prognosis and treatment (Review)
Zuzčák, M., & Trnka, J. (2022) · International Journal of Oncology · doi:10.3892/ijo.2022.5383 · Cited by 33
Dynamic Ginsenoside-Sheltered Nanocatalysts for Safe Ferroptosis-Apoptosis Combined Therapy
Zhao, X., Wu, J., Guo, D., Hu, S., Chen, X. '., Hong, L., Wang, J., Ma, J., Jiang, Y., Niu, T., et al. (2022) · Acta Biomaterialia · doi:10.1016/j.actbio.2022.08.026 · Cited by 32
Ferroptosis: Shedding Light on Mechanisms and Therapeutic Opportunities in Liver Diseases
You, H., Wang, L., Bu, F., Meng, H., Huang, C., Fang, G.-Y., & Li, J. (2022) · Cells · doi:10.3390/cells11203301 · Cited by 33
Miao, Y., Quan, W., Dong, X., Gan, J., Ji, C.-F., Wang, J., & Zhang, F. (2023) · Cell Death Discovery · doi:10.1038/s41420-023-01421-1 · Cited by 33
Yu, H., Zhao, H., Zhang, Y., Hou, Y., Li, R., Li, C., Zhang, M., Li, C., Zhao, J., Zhang, M., et al. (2023) · Chemical Engineering Journal · doi:10.1016/j.cej.2023.144690 · Cited by 32
CD98 heavy chain as a prognostic biomarker and target for cancer treatment
Pu, X., & Dubrovska, A. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1251100 · Cited by 35
Multiple myeloma with high expression of SLC7A11 is sensitive to erastin-induced ferroptosis
Zhang, W., Li, Q., Zhang, Y., Wang, Z., Yuan, S., Zhang, X., Zhao, M., Zhuang, W., & Li, B.-Z. (2023) · APOPTOSIS · doi:10.1007/s10495-023-01909-2 · Cited by 31
The crosstalk between oncogenic signaling and ferroptosis in cancer
Pang, Q., Tang, Z., & Luo, L. (2024) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2024.104349 · Cited by 32
Ferroptosis in immune cells: Implications for tumor immunity and cancer therapy
Gao, J., Zhang, X., Liu, Y., & Gu, X. (2025) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2025.06.007 · Cited by 34
Programmed cell death network in cancer drug resistance: A framework for therapeutic intervention
Guo, D., Guo, Y., Zhu, C., Liao, Y., Lin, Z., Zhang, H., Zhang, W., & Zou, Z. (2026) · Drug Resistance Updates · doi:10.1016/j.drup.2026.101387 · Cited by 36
Yan, J., Ye, G., & Shao, Y. (2022) · Journal of Clinical Laboratory Analysis · doi:10.1002/jcla.24317 · Cited by 31
Novel Therapeutic Savior for Osteosarcoma: The Endorsement of Ferroptosis
Qiu, C., Liu, T., Luo, D., Luan, D., Cheng, L., & Wang, S. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.746030 · Cited by 33
Self-citationMitochondrial regulatory mechanisms in spinal cord injury: A narrative review
Chengjiang, L., Liu, Y., Ma, B., Zhou, M., Zhao, X., Fu, X., Kan, S.-L., Hu, W., & Zhu, R. (2022) · Medicine · doi:10.1097/md.0000000000031930 · Cited by 31
Iron metabolism and ferroptosis in diabetic bone loss: from mechanism to therapy
Bao, J., Yan, Y., Zuo, D., Zhuo, Z., Sun, T., Lin, H., Han, Z., Zhao, Z., & Yu, H. (2023) · Frontiers in Nutrition · doi:10.3389/fnut.2023.1178573 · Cited by 33
Ferroptosis: a potential bridge linking gut microbiota and chronic kidney disease
Mao, Z., Gao, Z., Pan, S.-K., Liu, D., Liu, Z., & Wu, P. (2024) · Cell Death Discovery · doi:10.1038/s41420-024-02000-8 · Cited by 30
Targeting Metabolic–Redox Nexus to Regulate Drug Resistance: From Mechanism to Tumor Therapy
Wang, Y., He, J., Lian, S., Zeng, Y., He, S., Xu, J., Luo, L., Yang, W., & Jiang, J. (2024) · Antioxidants · doi:10.3390/antiox13070828 · Cited by 32
Ferroptosis, a therapeutic target for cardiovascular diseases, neurodegenerative diseases and cancer
Li, Y., Liu, C.-Y., Fang, B., Chen, X., Wang, K., Xin, H., Yang, S., & Yang, S. (2024) · Journal of Translational Medicine · doi:10.1186/s12967-024-05881-6 · Cited by 33
Gu, L., Sun, Y., Bai, T., Shao, S., Tang, S., Xue, P., Cai, W., Qin, X., Zeng, X., & Yan, S. (2025) · Journal of Nanobiotechnology · doi:10.1186/s12951-025-03284-3 · Cited by 34
Amrutkar, M., & Gladhaug, I. P. (2021) · Cancers · doi:10.3390/cancers13040601 · Cited by 31
Xia, H., Liang, Y., Chen, K., Guo, C., Wang, M., Cao, J., Han, S., Ma, Q., Sun, Y., & He, B. (2021) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2021.111733 · Cited by 30
Ferroptosis Meets Cell–Cell Contacts
Dietrich, C., & Hofmann, T. G. (2021) · Cells · doi:10.3390/cells10092462 · Cited by 30
Mechanisms of ferroptosis in chronic kidney disease
Zhuo, W.-Q., Wen, Y., Luo, H., Luo, Z., & Wang, L. (2022) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2022.975582 · Cited by 29
New insights in ferroptosis: Potential therapeutic targets for the treatment of ischemic stroke
Wei, Z., Xie, Y., Wei, M., Zhao, H., Ren, K., Feng, Q., & Xu, Y. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.1020918 · Cited by 34
Ferroptosis: A New Promising Target for Ovarian Cancer Therapy
Zhao, H., Xu, Y., & Shang, H. (2022) · International Journal of Medical Sciences · doi:10.7150/ijms.76480 · Cited by 30
Ferroptosis: A New Mechanism in Diabetic Cardiomyopathy
Song, Z., Wang, J., & Zhang, L. (2024) · International Journal of Medical Sciences · doi:10.7150/ijms.88476 · Cited by 30
Self-citationPaeoniflorin suppresses ferroptosis after traumatic brain injury by antagonizing P53 acetylation
Zhi, S., Cui, Y., Liu, Y., Zhang, J., Li, X.-J., Sheng, B., Chen, X.-X., Yan, C., Li, W., Mao, J.-N., et al. (2024) · Phytomedicine · doi:10.1016/j.phymed.2024.155940 · Cited by 30
Loo, T. M., Zhou, X., Tanaka, Y., Sugawara, S., Yamauchi, S., Kawasaki, H., Matsuoka, Y., Sugiura, Y., Sakuma, S., Yamanishi, Y., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-61894-9 · Cited by 35
Wang, Y., Peng, X., Zhang, M., Jia, Y., Yu, B., & Tian, J. (2020) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2020/9738143 · Cited by 30
Stoica, A.-F., Chang, C., & Pauklin, S. (2020) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2020.09.008 · Cited by 30
Downregulation of Cx43 reduces cisplatin-induced acute renal injury by inhibiting ferroptosis
Yu, M., Lin, Z., Tian, X., Chen, S., Liang, X., Qin, M., Zhu, Q., Wu, Y., & Zhong, S. (2021) · Food and Chemical Toxicology · doi:10.1016/j.fct.2021.112672 · Cited by 29
The Emerging Roles and Therapeutic Implications of Epigenetic Modifications in Ovarian Cancer
Wang, Y., Huang, Z., Li, B., Liu, L., & Huang, C. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.863541 · Cited by 30
Pan, Q., Lin, F., Liu, R., Li, Y., Zhang, X., Luo, R., Cai, L., Liu, Y., Deng, W., & He, L. (2023) · Chemical Engineering Journal · doi:10.1016/j.cej.2023.142962 · Cited by 30
Mitochondrial Regulation of Ferroptosis in Cancer Therapy
Cheng, X., Zhang, J., Xiao, Y., Wang, Z., He, J., Ke, M., Liu, S., Wang, Q., & Zhang, L. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241210037 · Cited by 29
Self-citationOrganic Selenium induces ferroptosis in pancreatic cancer cells
Noè, R., Inglese, N., Romani, P., Serafini, T., Paoli, C., Calciolari, B., Fantuz, M., Zamborlin, A., Surdo, N. C., Spada, V., et al. (2023) · Redox Biology · doi:10.1016/j.redox.2023.102962 · Cited by 30
Zhang, Z.-Q., Liang, X.-Y., Yang, X., Liu, Y., Zhou, X., & Li, C.-H. (2024) · ACS Applied Materials and Interfaces · doi:10.1021/acsami.3c15686 · Cited by 26
Sun, Y., Ma, Y., Shangguan, S., Ruan, Y., Bai, T., Xue, P., Zhuang, H., Cao, W., Cai, H., Tang, E., et al. (2024) · Journal of Nanobiotechnology · doi:10.1186/s12951-024-02747-3 · Cited by 28
Nanomaterial‐Triggered Ferroptosis and Cuproptosis in Cancer Therapy
Sahoo, S. S., & Manna, D. (2025) · Small · doi:10.1002/smll.202412462 · Cited by 28
Shi, X., Li, Q., Zhang, C., Pei, H., Wang, G., Zhou, H., Fan, L., Yang, K., Jiang, B., Wang, F., et al. (2021) · Journal of Nanobiotechnology · doi:10.1186/s12951-021-01083-0 · Cited by 28
Almeida‐Silva, J., Menezes, D., Fernandes, J. M. P., de Almeida, M. C., Vasco-dos-Santos, D. R., Saraiva, R. M., Viçosa, A. L., Perez, S. A. C., Andrade, S. G., Suarez-Fontes, A. M., et al. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.926699 · Cited by 30
Current insights into the regulation of programmed cell death by TP53 mutation in cancer
Su, Y., Sai, Y., Zhou, L., Liu, Z., Du, P., Wu, J., & Zhang, J. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.1023427 · Cited by 29
Treatment evaluation of Rheumatoid arthritis by in situ fluorescence imaging of the Golgi cysteine
Wang, H., Wen, N., Li, P., Xiu, T., Shang, S., Zhang, W., Zhang, W., Qiao, J., & Tang, B. (2023) · Talanta · doi:10.1016/j.talanta.2023.125532 · Cited by 28
Metadata
- Authors
- Badgley, M. A., Kremer, D. M., Maurer, H. C., DelGiorno, K. E., Lee, H.-J., Purohit, V., Sagalovskiy, I. R., Ma, A., Kapilian, J., Firl, C. E. M., Decker, A. R., Sastra, S. A., Palermo, C. F., Andrade, L. R., Sajjakulnukit, P., Zhang, L., Tolstyka, Z. P., Hirschhorn, T., Lamb, C., Liu, T., Gu, W., Seeley, E. S., Stone, E., Georgiou, G., Manor, U., Iuga, A., Wahl, G. M., Stockwell, B. R., Lyssiotis, C. A., & Olive, K. P.
- Affiliations
- Columbia University Irving Medical Center (US)
- University of Michigan (US)
- Salk Institute for Biological Studies (US)
- Division of Digestive and Liver Diseases, Department of Medicine, Columbia University Medical Center, New York, NY 10032, USA.
- Columbia University (US)
- The University of Texas at Austin (US)
- University of California, San Francisco (US)
- Corresponding author
- Kremer, Daniel M.
- Maurer, H. Carlo
- Olive, Kenneth P.
- ORCID
- Badgley, Michael A.
- Kremer, Daniel M.
- Maurer, H. Carlo
- DelGiorno, Kathleen E.
- Lee, Ho-Joon
- Purohit, Vinee
- Sagalovskiy, Irina R.
- Ma, Alice
- Kapilian, Jonathan
- Decker, Amanda R.
- Palermo, Carmine F.
- Andrade, Leonardo R.
- Sajjakulnukit, Peter
- Zhang, Li
- Hirschhorn, Tal
- Lamb, Candice
- Liu, Tong
- Gu, Wei
- Stone, Everett
- Georgiou, George
- Manor, Uri
- Iuga, Alina
- Wahl, Geoffrey M.
- Stockwell, Brent R.
- Lyssiotis, Costas A.
- Olive, Kenneth P.
- Venue
- Science
- Published
- 2020-04-03
- Volume
- 368
- Issue
- 6486
- Pages
- 85-89
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- PMC
- PMC7681911
- OpenAlex
- W3015020891
- Cited by
- 1,294
- References
- 41
- Citations by year
- 2026: 165 · 2025: 206 · 2024: 253 · 2023: 230 · 2022: 210 · 2021: 171 · 2020: 58
- FWCI
- 94.16
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institutes of Health (T32 A009503, F31 CA180738, 1R01CA215607, P30CA013696, U24-DK097153, P01CA087497, CA189623, CA014195, R35 CA197687, Cancer Center Core Grant CA014195, CA197687)
- National Cancer Institute (CA224272, R35CA209896)
- Damon Runyon Cancer Research Foundation (DFS-09-14)
- U.S. Department of Education
- U.S. Department of Defense (W81XWH-17-1-0497)
- Lustgarten Foundation (2011 Innovator Award)
- Sidney Kimmel Foundation for Cancer Research (SKF-16-005)
- Pancreatic Cancer Action Network (13-70-25-LYSS)
- The V Foundation for Cancer Research (V2016-009)
- Waitt Foundation
- Salk Women and Special Science Award
- The Freeberg Foundation (N/A)
- Leona M. and Harry B. Helmsley Charitable Trust (2012-PG-MED002)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Ferroptosis and cancer prognosis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cell death mechanisms and regulation
- Health Sciences › Medicine › Oncology › Pancreatic and Hepatic Oncology Research
- Keywords
- ferroptosis, cysteine depletion, pancreatic cancer, lipid reactive oxygen species, cancer therapy, tumor growth inhibition
- MeSH terms
- Ferroptosis, Animals, Cystathionine gamma-Lyase, Cysteine, Cystine, Humans, Mice, Mutant Strains, Pancreatic Neoplasms, Gene Deletion, Carcinoma, Pancreatic Ductal, Cationic Amino Acid Transporter 1, Cell Line, Tumor, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review